ArticleDevelopmental biology2026
Placode-derived orphan chemokine CXCL14 is critical for proper chick trigeminal ganglion formation.
Article in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The trigeminal ganglion, the largest of cranial sensory ganglia, has a dual origin from neural crest and ectodermal placode cells, which interact extensively during ganglion formation. In the developing chick embryo, we find that the orphan chemokine Cxcl14 is expressed in placode-derived cells at a time corresponding to when placode and neural crest cells, expressing the chemokine receptor Cxcr4, begin to condense into the trigeminal ganglion. In contrast, Cxcl12, the proposed canonical receptor for Cxcr4, is expressed in the frontonasal process and branchial arches, regions distant from the forming ganglion primordium. Importantly, CRISPR-Cas9 mediated knockout of Cxcl14 disrupted trigeminal ganglion formation, resulting in loss of the maxillomandibular lobe and reduction in the ophthalmic lobe as well as defective axonal projections. Taken together, these data reveal a new in vivo role for Cxcl14 during development and suggest a ligand-receptor interaction between CXCR4 and CXCL14, rather than CXCL12, during trigeminal ganglion development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.